Market Cap | 10.31B | P/E | 1,796.40 | EPS this Y | 23.90% | Ern Qtrly Grth | - |
Income | 14.23M | Forward P/E | 96.24 | EPS next Y | 37.80% | 50D Avg Chg | -16.00% |
Sales | 1.13B | PEG | 2.18 | EPS past 5Y | 15.60% | 200D Avg Chg | 3.00% |
Dividend | N/A | Price/Book | 9.70 | EPS next 5Y | 33.89% | 52W High Chg | -23.00% |
Recommedations | 2.10 | Quick Ratio | 3.58 | Shares Outstanding | 38.84M | 52W Low Chg | 94.00% |
Insider Own | 3.80% | ROA | 3.32% | Shares Float | 37.48M | Beta | 0.55 |
Inst Own | 93.33% | ROE | 1.28% | Shares Shorted/Prior | 2.63M/2.76M | Price | 269.46 |
Gross Margin | 62.51% | Profit Margin | 1.26% | Avg. Volume | 373,338 | Target Price | 204.69 |
Oper. Margin | -1.34% | Earnings Date | Oct 31 | Volume | 1,608,294 | Change | -9.68% |
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Stifel | Buy | Sep 17, 24 |
Leerink Partners | Outperform | Sep 3, 24 |
BTIG | Buy | Aug 28, 24 |
Citigroup | Neutral | Aug 22, 24 |
BTIG | Buy | Jul 31, 24 |
Baird | Outperform | Jul 31, 24 |
RBC Capital | Outperform | Jul 31, 24 |
Truist Securities | Buy | Jul 31, 24 |
Canaccord Genuity | Buy | Jul 31, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Sarna Surbhi | Director Director | Jan 02 | Sell | 247.68 | 85 | 21,053 | 2,295 | 01/04/24 |
Grewal Harpreet | Director Director | Jan 03 | Sell | 240.82 | 170 | 40,939 | 8,980 | 01/04/24 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Dec 27 | Option | 22.04 | 2,450 | 53,998 | 63,597 | 12/29/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Dec 01 | Sell | 225.41 | 600 | 135,246 | 62,251 | 12/05/23 |
O'Rourke Bridget | Director Director | Nov 30 | Sell | 226.41 | 150 | 33,962 | 4,214 | 12/04/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Nov 14 | Sell | 213.82 | 600 | 128,292 | 63,037 | 11/16/23 |
Elsesser Adam | CEO and President CEO and President | Oct 11 | Sell | 220.96 | 9,670 | 2,136,683 | 10/13/23 | |
Elsesser Adam | CEO and President CEO and President | Oct 11 | Option | 7.75 | 9,670 | 74,942 | 9,670 | 10/13/23 |
Shiu Lambert | Chief Accounting Off.. Chief Accounting Officer | Oct 09 | Option | 12.36 | 2,750 | 33,990 | 19,466 | 10/11/23 |
Grewal Harpreet | Director Director | Oct 02 | Sell | 240.99 | 170 | 40,968 | 9,150 | 10/04/23 |
Sarna Surbhi | Director Director | Oct 02 | Sell | 240.99 | 85 | 20,484 | 2,380 | 10/04/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Oct 02 | Sell | 238.59 | 600 | 143,154 | 63,637 | 10/04/23 |
Elsesser Adam | CEO and President CEO and President | Sep 11 | Sell | 298.4 | 9,666 | 2,884,334 | 09/13/23 | |
Elsesser Adam | CEO and President CEO and President | Sep 11 | Option | 7.75 | 9,666 | 74,912 | 9,666 | 09/13/23 |
Kassing Don W. | Director Director | Sep 08 | Sell | 288.66 | 444 | 128,165 | 1,458 | 09/12/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Sep 01 | Sell | 265.38 | 600 | 159,228 | 64,237 | 09/06/23 |
Grewal Harpreet | Director Director | Sep 01 | Sell | 266.62 | 340 | 90,651 | 9,320 | 09/06/23 |
Sarna Surbhi | Director Director | Sep 01 | Sell | 266.62 | 85 | 22,663 | 2,465 | 09/06/23 |
O'Rourke Bridget | Director Director | Sep 01 | Sell | 266.62 | 100 | 26,662 | 4,364 | 09/06/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Aug 14 | Sell | 249.14 | 600 | 149,484 | 64,837 | 08/16/23 |
Elsesser Adam | CEO and President CEO and President | Aug 11 | Sell | 247.41 | 9,666 | 2,391,465 | 08/14/23 | |
Elsesser Adam | CEO and President CEO and President | Aug 11 | Option | 7.75 | 9,666 | 74,912 | 9,666 | 08/14/23 |
Wilder Thomas | Director Director | Aug 07 | Sell | 253.48 | 340 | 86,183 | 340 | 08/09/23 |
Kassing Don W. | Director Director | Aug 08 | Sell | 251 | 323 | 81,073 | 1,902 | 08/09/23 |
Elsesser Adam | CEO and President CEO and President | Jul 11 | Option | 7.75 | 9,666 | 74,912 | 9,666 | 07/13/23 |
Elsesser Adam | CEO and President CEO and President | Jul 11 | Sell | 324.24 | 9,666 | 3,134,104 | 07/13/23 | |
Sarna Surbhi | Director Director | Jul 03 | Sell | 341.45 | 27 | 9,219 | 2,550 | 07/06/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Jul 03 | Sell | 340.63 | 900 | 306,567 | 65,437 | 07/06/23 |
Elsesser Adam | CEO and President CEO and President | Jun 12 | Sell | 324.26 | 9,666 | 3,134,297 | 06/14/23 | |
Elsesser Adam | CEO and President CEO and President | Jun 12 | Option | 7.75 | 9,666 | 74,912 | 9,666 | 06/14/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Jun 01 | Sell | 310.2 | 900 | 279,180 | 66,337 | 06/05/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | May 12 | Sell | 320.61 | 1,500 | 480,915 | 68,925 | 05/16/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | May 12 | Option | 22.04 | 652 | 14,370 | 70,425 | 05/16/23 |
Elsesser Adam | CEO and President CEO and President | May 11 | Sell | 319.05 | 9,666 | 3,083,937 | 05/15/23 | |
Elsesser Adam | CEO and President CEO and President | May 11 | Option | 7.75 | 9,666 | 74,912 | 9,666 | 05/15/23 |
Bose Arani | Director Director | May 01 | Sell | 286.22 | 5,000 | 1,431,100 | 182,629 | 05/03/23 |
Bose Arani | Director Director | Apr 03 | Sell | 275.93 | 5,000 | 1,379,650 | 431,342 | 04/05/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Apr 03 | Sell | 277.69 | 600 | 166,614 | 69,960 | 04/05/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Apr 03 | Option | 22.04 | 600 | 13,224 | 70,560 | 04/05/23 |
Sarna Surbhi | Director Director | Apr 03 | Sell | 276.37 | 28 | 7,738 | 2,577 | 04/05/23 |
Grewal Harpreet | Director Director | Mar 29 | Sell | 271 | 875 | 237,125 | 9,660 | 03/31/23 |
Grewal Harpreet | Director Director | Mar 15 | Sell | 254.98 | 875 | 223,108 | 10,535 | 03/17/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Mar 01 | Sell | 258.21 | 600 | 154,926 | 69,960 | 03/03/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Mar 01 | Option | 22.04 | 600 | 13,224 | 70,560 | 03/03/23 |
Grewal Harpreet | Director Director | Mar 01 | Sell | 259.48 | 710 | 184,231 | 11,410 | 03/03/23 |
Bose Arani | Director Director | Mar 01 | Sell | 258.38 | 5,000 | 1,291,900 | 436,342 | 03/03/23 |
Bose Arani | Director Director | Feb 01 | Sell | 253.89 | 5,000 | 1,269,450 | 440,662 | 02/03/23 |
Roberts Johanna | EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary | Dec 28 | Option | 22.04 | 5,750 | 126,730 | 69,960 | 02/03/23 |
Kassing Don W. | Director Director | Jan 27 | Sell | 243.54 | 693 | 168,773 | 1,545 | 01/31/23 |
Bose Arani | Director Director | Jan 23 | Sell | 250.25 | 20,000 | 5,005,000 | 445,662 | 01/25/23 |